The pathways upregulated, such as Ras/MAPK/PI3K/AKT, metabolism, Notch signaling, and axon guidance, are consistent with previous proteomic markers of GBM, ie. active tumor including the presence of stem cells. This evidence concerns the gene AKT1 and neoplasm.